The results showed that pimozide treatment significantly delayed the progression of tumor in the DLBCL PDX mouse model (Fig. 7a, b) and decreased the expression levels of cell proliferation-related protein Ki67 in tumors (Supplementary Fig. S5h, i). This evidence concerns the gene MKI67 and diffuse large B-cell lymphoma.